Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Search by expertise, name or affiliation
Neurological impact of vasopressin dysregulation and hyponatremia
Anish Bhardwaj
Research output
:
Contribution to journal
›
Review article
›
peer-review
46
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neurological impact of vasopressin dysregulation and hyponatremia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adverse Effects
14%
Antidiuretic Hormone
14%
Aquaresis
14%
Arginine Vasopressin
28%
Arginine Vasopressin Receptor
14%
Arginine Vasopressin Receptor Antagonists
28%
Brain Injury
14%
Cerebral Edema
14%
Clinical Experience
14%
Common Cause
14%
Controlled Experiment
14%
Dilutional Hyponatremia
14%
Dysregulation
100%
Electrolyte Balance
14%
Fluid Restriction
14%
Free Water Clearance
14%
Hyponatremia
100%
Inconsistent Responses
14%
Intracellular Compartments
14%
Na +
42%
Neurological Complications
14%
Neurological Diseases
14%
Neurological Disorders
14%
Neurological Effects
100%
Osmotic Demyelination
14%
Osmotic Stimuli
14%
Pharmacological Agents
14%
Rapid Correction
14%
Receptor Antagonism
14%
Renal Collecting Ducts
14%
Serum Osmolality
14%
Serum Sodium
14%
Treatment Agent
14%
Tubular Reabsorption
14%
Urine Osmolality
14%
V2 Receptor
14%
Vasopressin
100%
Water Balance
14%
Medicine and Dentistry
Argipressin
25%
Argipressin Receptor
37%
Brain Edema
12%
Brain Injury
12%
Collecting Duct
12%
Controlled Clinical Trial
12%
Demyelination
12%
Electrolyte Balance
12%
Free Water Clearance
12%
Hyponatremia
100%
Kidney Tubule Absorption
12%
Neurologic Disease
25%
Neurological Complication
12%
Neurosurgery
12%
Psychoactive Drug
12%
Serum Osmolality
12%
Side Effect
12%
Sodium Ion
37%
Vasopressin
100%
Vasopressin Receptor Antagonist
25%
Vasopressin V2 Receptor
12%
Pharmacology, Toxicology and Pharmaceutical Science
Argipressin
25%
Argipressin Receptor
37%
Brain Edema
12%
Brain Injury
12%
Controlled Clinical Trial
12%
Demyelination
12%
Hyponatremia
100%
Neurologic Disease
25%
Neurological Complication
12%
Psychotropic Agent
12%
Side Effect
12%
Sodium Ion
37%
Vasopressin
100%
Vasopressin Receptor Antagonist
25%
Vasopressin V2 Receptor
12%